Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis

This publication has 47 references indexed in Scilit:

• Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages
  Life Sciences, 1996
• Monocyte-related cytokines in acute myocardial infarction
  American Heart Journal, 1995
• Myocardial contractile dysfunction in the systematic inflammatory response syndrome: Role of a cytokine-inducible nitric oxide synthase in cardiac myocytes
  Journal of Molecular and Cellular Cardiology, 1995
• Vesnarinone prolongs survival and reduces lethality in a murine model of lethal endotoxemia
  Life Sciences, 1994
• Increased circulating cytokines in patients with myocarditis and cardiomyopathy.
  Heart, 1994
• Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.
  Journal of Clinical Investigation, 1994
• Clinical effects of long-term administration of pimobendan in patients with moderate congestive heart failure
  Heart and Vessels, 1994
• Long Term Survival of Class IV Heart Failure Patients Treated with Oral Amrinone
  The Journal of Clinical Pharmacology, 1989
• Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
  Circulation, 1985
• An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus.
  Circulation, 1982